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Health Sciences, Hiroshima, Japan.Introduction
Device interrogation sometime provides useful informa-
tion about previous arrhythmic events. We describe a
patient with atrioventricular (AV) block in whom a pace-
maker interrogation found the unpredictable cause of pleu-
ral effusion.Case summary
A 49-year-old man experienced syncope while he crossed a
street, and he was transferred to our hospital. An electro-
cardiogram (ECG) showed a second-degree 2:1 atrioven-
tricular block with narrow QRS complexes (Figure 1A).
Curiously, the RR intervals were not constant while the
PP intervals remained steady during the 2:1 AV block
(Figure 1B). The echocardiogram revealed a normal left
ventricular systolic function and no morphologic abnor-
malities. No signiﬁcant coronary stenosis was observed
on the coronary angiogram. No electrolyte abnormalities
were noted. He did not have any relevant medical history
and did not take any medications. Because the 2:1 AV
block did not improve, a dual-chamber pacemaker (Advisa
DR MRI A3DR01, Medtronic, Minneapolis, MN) was
implanted.
The alternating RR intervals during the 2:1 AV block seen
in the present case were uncommon. A quite similar ECG
ﬁnding was however previously reported.1 The authors
offered the concealed conduction concept as the causal
mechanism.2 The term “concealed conduction” is used when
a proximal atrial impulse penetrates the AV node but fails toKEYWORDS Atrioventricular block; Autonomic tone; Tachycardia-induced
cardiomyopathy
ABBREVIATIONS AF ¼ atrial fibrillation; AT ¼ atrial tachycardia;
AV ¼ atrioventricular; ECG ¼ electrocardiogram
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).traverse it completely. The concealed penetration into the
AV node is inferred by its aftereffects on the propagation of
succeeding impulses. The authors speciﬁcally described the
phenomenon as follows. When blocked atrial impulses
penetrate deeper into the AV junction, the subsequent PR
intervals are long, while the impulses blocked at its shallow
level are followed by shorter PR intervals. Importantly, they
stated that when 2 levels of concealment are postulated in an
ECG showing normal QRS complexes, the conduction
disturbance is most probably conﬁned within the AV node.
Thus, the interesting phenomenon we observed suggested
that our patient may have had intranodal block rather than
infranodal block. The former is generally considered more
benign than the latter.3 The current guidelines,3 however,
clearly state that permanent pacemaker implantation is
indicated for second-degree AV block with associated
symptomatic bradycardia, regardless of the site of the block.
His pacemaker implantation was based on this guideline.
One year later, the patient saw his family physician for
dyspnea on effort. A chest radiograph demonstrated a pleural
effusion. He was prescribed 20 mg of furosemide. He had a
quick improvement in his symptom, and the pleural effu-
sion was no longer seen 2 weeks after his initial visit.
The furosemide was then withdrawn. He never experienced
the recurrence of the symptom. Another 8 months later, he
was seen in our outpatient clinic for a regular pacemaker
check.
There are a wide variety of diseases that can result in pleural
effusion.4 However, given that only a brief administration of
the oral diuretic cured his pleural effusion without recurrence,
any chronic disease or disease resulting in irreversible damage
was unlikely. Anyway, he had never presented with the
symptom until he was implanted with the pacemaker. There-
fore, it was essential to check for any pacemaker-related
defects, such as pacemaker failure, lead perforations, or heart
failure due to chronic right ventricular pacing.
The echocardiogram ﬁndings and lead positions remained
the same, and no pacemaker failure was noted. Instead, a
number of atrial ﬁbrillation (AF) or atrial tachycardia (AT)
events were recorded by the pacemaker (Figure 2A). Duringpen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 Alternations of the ventricular cycle length could
be observed even during 2:1 second-degree
atrioventricular (AV) block, and this observation
may be explained by different depths at which
blocked impulses penetrate into the AV junction.
 Tachycardia-induced cardiomyopathy could be one
of the causes of decompensated heart failure, even
in patients with AV block needing a pacemaker.
 Interrogation of pacemakers often provides some
clues about the cause of previous cardiac events.
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from DDD to DDIR. An extremely rapid ventricular
response was noted during some AT/AF events, in particular
soon after the beginning of the AT/AF events (Figure 2B). A
cardiac compass report (Figure 2C) showed that the AT/AF
persisted for about 6½ months and terminated spontane-
ously. A medical interview with the patient proved that his
dyspnea coincided with the ﬁrst occurrences of the AT/AF
events. According to the records of the thoracic impedance in
his pacemaker, it markedly decreased also soon after the
beginning of the AT/AF events (Figure 2D).Figure 1 A: An electrocardiogram recorded at the patient’s initial clinical visit.
electrocardiogram at the initial clinical visit. The RR intervals were irregular durinA double-chamber tachycardia was carefully ruled out via
device interrogation. It was therefore assumed that the
patient developed tachycardia-induced cardiomyopathy sec-
ondary to a rapid AT/AF, resulting in acute decompensated
heart failure.5 He obviously had symptomatic second-degree
AV block requiring a pacemaker 20 months before the last
clinical visit. Thus, the rapid ventricular response during the
AT/AF was very unlikely if his AV conductivity remained
severely impaired. Prior to the pacemaker implantation, we
carefully excluded any potential reversible causes of AV
block, such as drug toxicity, electrolyte abnormalities,
diseases with periatrioventricular node inﬂammation, tran-
sient injury or ischemia of the conduction system, or hyper-
vagotonia.3 It is known that AV block could be reversed
transiently in patients with cardiac sarcoidosis.3 However,
the ﬁndings from his multiple echocardiographic exam-
inations, ECGs, and device interrogations never suggested
cardiac sarcoidosis.6 Did his AV block then heal spontan-
eously?
The patient presented with sinus rhythm at 68 beats per
minute and a prolonged PQ interval of 270 milliseconds
when the sensed AV delay of the pacemaker was changed
from 150 to 300 milliseconds. The Wenckebach cycle length
was determined to be 720 milliseconds (Figure 3), and the
AV nodal effective refractory period was found to be 620
milliseconds. He was prescribed 5 mg of bisoprolol.A 2:1 atrioventricular block was noted. B: A long-duration recording of an
g 2:1 atrioventricular block.
Figure 2 A: A device interrogation illustrating an event of an atrial arrhythmia with a cycle length of 240–280 milliseconds and irregular atrioventricular
conductions. B: A device interrogation illustrating an event of an atrial arrhythmia with 1:1 atrioventricular conductions. C: A summary of the duration of the
atrial tachycardia (AT)/atrial ﬁbrillation (AF) burden and average or maximum heart rate during the AT/AF. D: The time course of the thoracic impedance.
109Sairaku et al Unpredictable Cause of Heart FailureAlthough his third-degree AV block improved to ﬁrst-
degree AV block 20 months after the pacemaker implanta-
tion, the AV conductivity at rest still remained morbidly
impaired. Why, then, did such a rapid ventricular response
occur during AT/AF?Figure 3 An intracardiac recording during atrial pacing. WenckebachCommentary
The following is a putative mechanism for the obser-
ved phenomenon. An increased sympathetic activity with
or without decreased parasympathetic tone elicited the AT/
AF.7 Alternatively, the AT/AF itself activated theperiodicity was seen at an atrial pacing cycle of 720 milliseconds.
Heart Rhythm Case Reports, Vol 2, No 1, January 2016110sympathetic system.8 This autonomic change also improved
the patient’s deteriorated AV conduction. The excessively
increased ventricular rate and atrioventricular asynchrony in
turn impaired the diastolic ﬁlling, resulting in a reduction in the
cardiac output.9 This occurrence further increased the sympa-
thetic activity. The patient fell into this vicious cycle. Because
he presented with ﬁrst-degree AV block at the last visit, his site
of block was likely to be within the AV node.10 This hypothesis
was actually consistent with our expectation before the pace-
maker implantation. As is well known, the AV node is strongly
inﬂuenced by the autonomic system.11 Therefore, if the
hypothesis is correct, the dramatic change in the autonomic
tone was possibly a key mechanism whereby the deteriorated
AV conductivity strikingly and even harmfully improved.
The important limitations were that we did not assess his
AV conduction properties with the use of isoproterenol,
atropine, or exercise testing, and we did not record a His
bundle ECG. Finally, it was possible that antiarrhythmic drugs
such as amiodarone were more appropriate than bisoprolol for
the secondary prevention of his harmful tachycardia.References
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